CCNQP2

Across TCGA pan-cancer cohorts, CCNQP2 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of CCNQP2’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where CCNQP2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CCNQP2 is over-expressed in tumor.

UCEC, ESCA, and PRAD are the cancer types where CCNQP2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CCNQP2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	II,III,IV	+0.079	.030	4	view →
ESCA	All	II,III,IV	+0.085	.029	2	view →
PRAD	All	All	+0.019	.032	2	view →
COAD	All	II,III,IV	+0.054	.046	1	view →
KIRC	Male	All	+0.008	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

CCNQP2–UCEC

Open the UCEC breakdown →